Home › NDC Lookup › RxCUI directory › RxCUI 310353

Fluconazole 40 MG/ML Oral Suspension — RxCUI 310353

RxNorm drug concept · Semantic clinical drug
RxCUI 310353 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310353
Official nameFluconazole 40 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluconazole 40 MG per 1 ML Oral Suspension; fluconazole 40 MG in 1 mL Oral Suspension; fluconazole 1400 MG per 35 ML Oral Suspension; fluconazole 200 MG per 5 ML Oral Suspension; fluconazole 40 MG per ML Powder for Oral Suspension
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)93,463 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluconazole Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is typically used when you're in a hospital setting and need treatment quickly, can't swallow pills or keep them down, or have a serious systemic infect...
  • Why am I getting fluconazole through an IV instead of a pill?
  • It really depends on the type of infection you have. A mouth or throat infection might be treated for at least two weeks, while a more serious infection like cryptococcal meningiti...
  • How long will I need to be on this medication?
📖 Read our full Fluconazole Injection guide →

🕸️ Concept Web — How Fluconazole 40 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluconazole 40 MG/ML Oral Suspension RxCUI 310353

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fluconazole 4450
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Diflucan 202813
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluconazole Oral Suspension 372209
    • Fluconazole Oral Liquid Product 1160235
    • Fluconazole Oral Product 1160236
    • Fluconazole Oral Suspension [Diflucan] 403145
    • Diflucan Oral Liquid Product 1168176
    • Diflucan Oral Product 1168177
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluconazole 40 MG/ML SCDC · 317374
  • Fluconazole Oral Suspension SCDF · 372209
  • Fluconazole Oral Liquid Product SCDG · 1160235
  • Fluconazole Oral Product SCDG · 1160236

Brand-Name Concepts

  • Fluconazole 40 MG/ML Oral Suspension [Diflucan] SBD · 201901
  • Fluconazole 40 MG/ML [Diflucan] SBDC · 566047
  • Fluconazole Oral Suspension [Diflucan] SBDF · 403145
  • Diflucan Oral Liquid Product SBDG · 1168176
  • Diflucan Oral Product SBDG · 1168177
  • Diflucan BN · 202813

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 310353 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00049-3450-19 1 BOTTLE in 1 CARTON (0049-3450-19) / 35 mL in 1 BOTTLE Diflucan Roerig 1993-12-23
16714-0695-01 1 BOTTLE in 1 CARTON (16714-695-01) / 35 mL in 1 BOTTLE Fluconazole NorthStar Rx LLC 2009-09-18
16714-0696-01 1 BOTTLE in 1 CARTON (16714-696-01) / 35 mL in 1 BOTTLE Fluconazole NorthStar Rx LLC 2009-09-18
57237-0149-35 1 BOTTLE in 1 CARTON (57237-149-35) / 35 mL in 1 BOTTLE Fluconazole Rising Pharma Holdings, Inc. 2009-09-18
57237-0150-35 1 BOTTLE in 1 CARTON (57237-150-35) / 35 mL in 1 BOTTLE Fluconazole Rising Pharma Holdings, Inc. 2009-09-18
59762-5029-01 1 BOTTLE in 1 CARTON (59762-5029-1) / 35 mL in 1 BOTTLE Fluconazole Mylan Pharmaceuticals Inc. 1993-12-23
59762-5030-01 1 BOTTLE in 1 CARTON (59762-5030-1) / 35 mL in 1 BOTTLE Fluconazole Mylan Pharmaceuticals Inc. 1993-12-23
65862-0299-35 1 BOTTLE in 1 CARTON (65862-299-35) / 35 mL in 1 BOTTLE Fluconazole Aurobindo Pharma Limited 2009-09-18
65862-0300-35 1 BOTTLE in 1 CARTON (65862-300-35) / 35 mL in 1 BOTTLE Fluconazole Aurobindo Pharma Limited 2009-09-18
70436-0227-48 1 BOTTLE in 1 CARTON (70436-227-48) / 35 mL in 1 BOTTLE Fluconazole Slate Run Pharmaceuticals 2024-01-01
72673-0091-14 1 BOTTLE in 1 CARTON (72673-091-14) / 35 mL in 1 BOTTLE Fluconazole Zhejiang Poly Pharm. Co., Ltd. 2025-04-01
Observed labelers: Aurobindo Pharma Limited (2) · Mylan Pharmaceuticals Inc. (2) · NorthStar Rx LLC (2) · Rising Pharma Holdings, Inc. (2) · Roerig (1) · Slate Run Pharmaceuticals (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.